Photonova’s PCCT technology’s ‘universal scan’ approach is designed to drive efficiencies and reduce complexity across ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best large cap value stocks to buy according to analysts. On March 23, GE HealthCare received FDA 510(k) clearance for its Photonova Spectra ...

GE HealthCare is raising the curtain on its spearhead into the field of photon-counting CT, the Photonova Spectra, with an announcement that the system has been submitted to the FDA for review. The ...

Following its curtain-raising at last fall’s meeting of the Radiological Society of North America, GE HealthCare has obtained ...

GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ ...

Seyedamir Tavakoli Taba from the University of Sydney is investigating the use of propagation-based phase-contrast CT for breast cancer diagnosis. Propagation-based phase-contrast CT (PB-CT) is an ...

Photonova Spectra i is the first in the next generation of spectral photon counting CT systems with 8-bins of energy resolution, powered by GE HealthCare’s proprietary Deep Silicon detector technology ...

A heart CT scan uses X-rays to create an image of the heart and blood vessels. Healthcare professionals may also refer to it as cardiac CT angiography. A CT scan is a noninvasive imaging procedure.

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...

The 510(k) decision clears the company to challenge Siemens Healthineers for an emerging part of the CT imaging sector.